MedTravest II ApS: Financial statements 2024
CVR: 42368032
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MedTravest II ApS (CVR 42368032) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -19,000 and a net result of DKK -23,546 compared with DKK -18,750 the year before. Equity in the 2024 report amounted to DKK 7,643,673. The solvency ratio was 99%.
- Gross Profit
- DKK -19,000
- Profit/Loss
- DKK -23,546
- Equity
- DKK 7,643,673
- Total Assets
- DKK 7,724,625
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -19K | -24K | 7.6M | - |
| 2023 | - | -19K | -19K | 7.7M | - |
| 2022 | - | - | -38K | 7.7M | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MedTravest II ApS has published its annual report for 2023. Gross profit came to DKK -18,750, and the net result was DKK -18,750.
About MedTravest II ApS
MedTravest II ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named ApS STAKE nr. 6158. The management consists of Jens Strathe. The board consists of Mark Lund Andersen (chair), Jens Strathe and Tore Jesper Andersen. The company's owners include STRATHE INVEST ApS, JUUL KRISTENSEN HOLDING ApS and MedTravest A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -186,772 and a net result of DKK -186,772 compared with DKK -23,546 the year before. Equity in the 2025 report amounted to DKK 7,565,001.